Kendrion successfully raises €31.1 million through an accelerated bookbuild offering of ordinary shares

Alleen voor leden beschikbaar, wordt daarom gratis lid!

Overig advies 22/11/2019 07:15
Kendrion N.V. (AMS: KENDR), hereinafter the "Company" or "Kendrion", announces that is has successfully placed 1,593,078 ordinary shares, representing approximately 12% of the Company’s issued share capital, at an issue price of €19.50 per ordinary share, thereby raising approximately €31.1 million through an accelerated bookbuild offering (the "Offering").

The ordinary shares placed in the Offering consist of 1,357,486 new ordinary shares (the "New Shares"), representing 10% of the Company’s issued share capital as at the date of the annual general meeting of the Company held on 8 April 2019, and 235,592 existing ordinary shares which the Company currently holds in treasury (the "Treasury Shares" and together with the New Shares, the "Offered Shares"), representing c.2% of the Company’s current issued share capital.

The Company intends to use the net proceeds from the Offering to refinance the committed bridge loan obtained to partially finance the acquisition of INTORQ which was previously announced on 5 November 2019 (the "Acquisition").

In relation to the Offering, the Company is subject to a market customary lock-up period ending 90 calendar days after the issue date, subject to customary exceptions and waivable by the Global Coordinator.

Settlement of the Offered Shares and admission to listing and trading of the New Shares on Euronext Amsterdam is expected to take place on 26 November 2019. On settlement of the Offering, Kendrion will have a total of 14,933,950 ordinary shares issued.

ING Bank N.V. acted as Sole Global Coordinator and Sole Bookrunner in the Offering.

Beperkte weergave !
Leden hebben toegang tot meer informatie! Omdat u nog geen lid bent of niet staat ingelogd, ziet u nu een beperktere pagina. Wordt daarom GRATIS Lid of login met uw wachtwoord

Copyrights © 2000 by all rights reserved
Niets mag zonder toestemming van de redactie worden gekopieerd, linken naar deze pagina is wel toegestaan.